J. Jefferson Smith - 02 Jun 2025 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Research Officer
Signature: /s/ Dario Scimeca Attorney-in-fact for Jeff Smith
Issuer symbol: DTIL
Transactions as of: 02 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2025, 17:00:45 UTC
Previous filing: 05 Mar 2025
Next filing: 22 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SMITH J. JEFFERSON	Chief Research Officer	C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM	/s/ Dario Scimeca Attorney-in-fact for Jeff Smith	04 Jun 2025	0001770169

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Award	$0	+50,000		$0.000000	50,000	02 Jun 2025	Common Stock	50,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.